By Sruthi Shankar and Devik Jain (Reuters) -European shares rose on Tuesday, lifted by rallying oil stocks after a rout in the previous session, as investors looked toward the next batch of data for clues on the health of the continent amid mixed signals from policymakers on the path of interest rates. The pan-European STOXX …
European shares end higher as oil stocks rebound Read More »
By Shashwat Chauhan (Reuters) -The FTSE 100 jumped to a two-month high on Tuesday, as oil stocks bounced back following a bullish comment on the sector by a brokerage and news that OPEC+ members were not discussing an oil output increase. The commodities-heavy FTSE 100 closed 1% higher, to hit its strongest level since Sept. …
Oil stocks power FTSE 100 to over two-month high Read More »
COPENHAGEN (Reuters) -Danish drug maker Novo Nordisk said on Tuesday it plans to invest 5.4 billion Danish crowns ($744 million) to expand its facilities in Bagsvaerd, Denmark. The world’s biggest producer of diabetes drugs, Novo said the project is expected to be finalised in 2024 and create about 160 new jobs. The investment would add …
Drug maker Novo Nordisk invests $744 million to expand Danish plant Read More »
PARIS (Reuters) – French spirits group Pernod Ricard is confident that its business in Europe, the Middle East, Africa and Latin America (EMEA/LATAM) will continue to deliver above market sales growth while protecting its margins in the 2023 fiscal year, EMEA-LATAM CEO Gilles Bogaert said on Tuesday. Bogaert was speaking in a video clip ahead …
Pernod Ricard confident about Europe, Mid-East, Africa and Latam business Read More »
BRUSSELS (Reuters) – The European Commission proposed introducing a gas price cap for one year from Jan.1, 2023, according to a draft legislation seen by Reuters that, however, has so far left the actual ceiling level blank. The idea to cap prices has divided EU countries for many months. The Commission’s latest proposal will be …
EU gas cap seen in place for one year, countries spar over price level Read More »
LONDON (Reuters) -Network equipment maker Ericsson will invest millions of pounds in 6G mobile research in Britain, it said on Tuesday, working with universities on hardware security, AI and cognitive networks and quantum computing. The Swedish company, which supplies 5G gear to all four British mobile networks, said the 10-year initiative would help to drive …
Ericsson to invest in 6G network research in Britain Read More »
VIENNA (Reuters) – Austria should keep its recently introduced compulsory standards for mortgage lending, the Austrian National Bank (ONB) said on Tuesday, despite a recent call by the conservative finance minister for those standards to be reviewed. Faced with a sustained housing boom and banks’ widespread flouting of recommendations on mortgage lending aimed at limiting …
Austrian central bank defends compulsory mortgage-lending standards Read More »
BERLIN (Reuters) – German industrial production is on track to rise slightly this year thanks to order backlogs but the outlook for 2023 is gloomy as high energy prices and geopolitical uncertainties hurt businesses, the BDI industry association said on Tuesday. The BDI said it expected a slight increase in production of around 0.25% this …
German 2022 industry output to rise slightly, 2023 looks gloomy – BDI Read More »
By Diana Mandia (Reuters) -France’s Orpea, hit by allegations of malpractice at its French retirement homes, on Tuesday said it would pay back the entire 55.8 million euros ($57.2 million) claimed by the national fund that finances living assistance for the elderly and disabled. “With a view to turning the page on errors of the …
Nursing home group Orpea to pay back entire 56 million euro public grants Read More »
By Pushkala Aripaka (Reuters) – GSK will stop selling its blood cancer drug Blenrep in the United States, it said on Tuesday, representing the latest in a series of setbacks for the British drugmaker’s oncology business. The company had said this month that Blenrep failed the main goal of a key study designed to show …
GSK to stop selling blood cancer drug Blenrep in United States Read More »
